Key account managers for pharma brands can call on a major healthcare system and simultaneously change behavior in 1,000 HCPs. So it's really a B2B sell, explains The Kinetix Group's John Strapp.
After a scandal with one of point of care's biggest players, we examine how the community is living up to its promise of greater transparency.
Congress has finally passed the Right to Try Act, but does it go far enough?
Health agencies are in acquisition mode, with networks snapping up independents, and the M&A market looks poised to stay hot.
Prophet surveyed 240 healthcare organizations to find out where the industry is actually at on its shift to consumer centricity.
Find out who made award-winning work this year.
Doner will lead a branding effort for the health system that will roll out in 2019.
Wednesday's reorg was designed to position the company for growth in the face of the imminent patent cliff for megablockbuster Lyrica.
Ad agency GSW and parent company Syneos Health are all about healthcare. A conversation with GSW's Sonja Foster-Storch, president, North America, and Michael Austin, managing director, creative and technology, on why that's important.
This year's version of the Agency 100 aims to give you the most complete guide to disruptions in the environment in which agencies operate, ranging from fresh data privacy and security worries, to newer kinds of innovation and enterprise technology work.
How can consumer marketing behavior be integrated into the clinical trial space? At Cannes, Angela Radcliffe, GM of clinical trial solutions at PulsePoint, and Mark Evans, innovation director at Langland, discuss why it's imperative to change how clinical trials are marketed.
Synapse executive vice president Kerry Murphy explains the struggles and triumphs of the real-world applications of data analytics.
Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?
According to a 2014 study conducted by The Human Rights Campaign, the largest LGBTQ civil rights advocacy group in the U.S., 53% of all LGBTQ workers nationwide "hide who they are in the workplace."
Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.
It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.
A combination of traditional and modern comms tactics help molecular diagnostic testing company Interpace craft messages that resonate with all key audiences.
Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.
Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.
Healthcare journalists and communicators have an obligation to facilitate informed conversation, not simply put out information. Does the Times' take on a recent gene test live up to that standard?
MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.
New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior
MM&M/Publicis Health's first Diversity Survey reveals some notable shifts to making the healthcare industry more inclusive, yet many agencies didn't feel like opening up about their diversity numbers.
A UK drug regulator has ruled that a 2017 press release from AstraZeneca was "misleading" as data "had not been presented in a balanced way", following a complaint from a fellow pharma firm.
Legalization of the drug for medical use is already having an impact on prescription patterns. But for patients and doctors alike, there are a lot of unanswered questions.
As deepening healthcare forays by tech and e-commerce giants ratchet up the pressure on pharma to become more consumer friendly, drugmakers are still defining their new role.
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
Alisa Lask is VP and GM, U.S. aesthetic business unit of Galderma, Nestlé Skin Health.
Neera Chaudhary is global president of healthcare of Golin.
Wendy Blackburn is EVP, marketing and communications of Intouch Solutions.